Jeff June – Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
Jeff June, Innovation Advisor at Early Stage Digital Health, MedTech, Venture Capital, and Accelerator Programs, posted on LinkedIn:
”I just published an article (click link or image below) about a grant program to advance your start up in spatial biology.
I’m also including my abstract (also in the article link) for leveraging a Miltenyi Biotec MACS Imaging Grant to apply spatial biology in stroke care.
I hope people in my network will apply for this opportunity (looking at you University Lab Partners, BioTools Innovator, MedTech Innovator, National Science Foundation (NSF), Gates Foundation).
I encourage anyone exploring spatial biology, imaging, or molecular diagnostics to apply before October 31st.
For me, this was more than an application – it’s part of how we’re redefining stroke diagnostics at Ischemia Care. Our RNA-based assay (ISCDx) has already shown that blood can reveal the mechanism of stroke, but this next step uses spatial biology to see those molecular interactions: how hashtag#vascular and immune cells communicate, how inflammation drives recurrence, and how molecular signatures translate into clinical outcomes.
As we enter a new era of cardiovascular and neurovascular medicine, integrating molecular diagnostics + AI + spatial imaging isn’t just exciting science – it’s how we’ll prevent the next stroke (or maybe someday any stroke) before it happens.
If you’re working at this intersection, or building translational tools that turn biology into actionable data, let’s connect. This is where the next generation of precision care begins.”
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia